Relationships of Different Blood Pressure Categories to Indices of Inflammation and Platelet Activity in Sustained Hypertensive Patients with Uncontrolled Office Blood Pressure

References

• Ayala DE, Moyá A, Crespo JJ, et al. (2013). Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol Int, 30, 99–115
   PubMed Web of Science ®Google Scholar
• Bath PM, Butterworth RJ. (1996). Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis, 7, 157–61
   PubMed Web of Science ®Google Scholar
• Björklund K, Lind L, Zethelius B, et al. (2004). Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. J Hypertens, 22, 1691–7
   PubMed Web of Science ®Google Scholar
• Bo S, Gambino R, Durazzo M, et al. (2005). Associations between gamma-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: a possible implication for oxidative stress. World J Gastroenterol, 11, 7109–17
   PubMed Web of Science ®Google Scholar
• Caliskan M, Erdogan D, Gullu H, et al. (2007). Association between serum gamma-glutamyltransferase levels and coronary microvascular function in hypertensive patients. J Hypertens, 25, 2497–503
   PubMed Web of Science ®Google Scholar
• Campion EW, Glynn RJ, DeLabry LO. (1987). Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med, 82, 421–6
   PubMedGoogle Scholar
• Clement DL, De Buyzere ML, De Bacquer DA, et al. (2003). Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med, 348, 2407–15
   PubMed Web of Science ®Google Scholar
• Coats AJ, Radaelli A, Clark SJ, et al. (1992). The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertens, 10, 385–91
   PubMed Web of Science ®Google Scholar
• Daskalopoulou SS, Khan NA, Quinn RR, et al. (2012). The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol, 28, 270–87
   PubMed Web of Science ®Google Scholar
• D’Erasmo E, Aliberti G, Celi FS, et al. (1990). Platelet count, mean platelet volume and their relation to prognosis in cerebral infarction. J Intern Med, 227, 11–14
   PubMed Web of Science ®Google Scholar
• Ermis N, Yagmur J, Acikgoz N, et al. (2012). Serum gamma-glutamyl transferase (GGT) levels and inflammatory activity in patients with non-dipper hypertension. Clin Exp Hypertens, 34, 311–5
   PubMed Web of Science ®Google Scholar
• Fagard RH, Celis H, Thijs L, et al. (2008). Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension, 51, 55–61
   PubMed Web of Science ®Google Scholar
• Fessel WJ. (1980). High uric acid as an indicator of cardiovascular disease. Independence from obesity. Am J Med, 68, 401–4
   PubMed Web of Science ®Google Scholar
• Genest J, McPherson R, Frohlich J, et al. (2009). 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult—2009 recommendations. Can J Cardiol, 25, 567–79
   PubMed Web of Science ®Google Scholar
• Hermida RC, Calvo C, Ayala DE, López JE. (2005). Decrease in urinary albumin excretion associated with the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension, 46, 960–8
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Chayan L, et al. (2009). Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol Int, 26, 61–79
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, et al. (2010). Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing. Chronobiol Int, 27, 1287–303
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, et al. (2011a). Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing. Chronobiol Int, 28, 601–10
   PubMed Web of Science ®Google Scholar
• Hermida RC, Chayán L, Ayala DE, et al. (2011b). Relationship between metabolic syndrome, circadian treatment time, and blood pressure non-dipping profile in essential hypertension. Chronobiol Int, 28, 509–19
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Crespo JJ, et al. (2013a). Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients. Chronobiol Int, 30, 176–91
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernández JR, Mojón A. (2013b). Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int, 30, 68–86
   PubMed Web of Science ®Google Scholar
• Kaya MG, Yarlioglues M, Gunebakmaz O, et al. (2010). Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis, 209, 278–82
   PubMed Web of Science ®Google Scholar
• Kikuya M, Ohkubo T, Asayama K, et al. (2005). Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension, 45, 240–5
   PubMed Web of Science ®Google Scholar
• Lee DH, Jacobs DR Jr, Gross M, et al. (2003). Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem, 49, 1358–66
   PubMed Web of Science ®Google Scholar
• Lee DH, Jacobs DR Jr, Gross M, Steffes M. (2005). Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem, 51, 1185–91
   PubMed Web of Science ®Google Scholar
• Mancia G, Omboni S, Parati G, et al. (2001). Twenty four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study. J Hypertens, 19, 1755–63
   PubMed Web of Science ®Google Scholar
• Mancia G, Parati G, Bilo G, et al. (2007). Assessment of long-term antihypertensive treatment by clinic an ambulatory blood pressure. Data from the ELSA Study. J Hypertens, 25, 1087–94
   PubMed Web of Science ®Google Scholar
• Mansia G, De Backer G, Dominiczak A, et al. (2007). 2007 ESH-ESC Guidelines for the Management of Arterial Hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press, 16, 135–232
   PubMed Web of Science ®Google Scholar
• Nadar SK, Blann AD, Kamath S, et al. (2004). Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol, 44, 415–22
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int, 27, 1911–29
   PubMed Web of Science ®Google Scholar
• Ruttmann E, Brant LJ, Concin H, et al. (2005). Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation, 112, 2130–7
   PubMed Web of Science ®Google Scholar
• Sega R, Facchetti R, Bombelli M, et al. (2005). Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation, 111, 1777–83
   PubMed Web of Science ®Google Scholar
• Staessen JA, Asmar R, De Buyzere M, et al. (2001). Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit, 6, 355–70
   PubMed Web of Science ®Google Scholar
• Svensson P, de Faire U, Sleight P, et al. (2001). Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy. Hypertension, 38, E28–32
   PubMed Web of Science ®Google Scholar
• Tsioufis C, Syrseloudis D, Dimitriadis K, et al. (2008). Disturbed circadian blood pressure rhythm and C-reactive protein in essential hypertension. J Hum Hypertens, 22, 501–8
   PubMed Web of Science ®Google Scholar
• Turnbull F; Blood Pressure Lowering Treatment Trialists’ Collaboration. (2003). Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet, 362, 1527–35
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Borgioni C, et al. (1997). Altered circadian blood pressure profile and prognosis. Blood Press Monit, 2, 347–52
   PubMedGoogle Scholar
• Ward HJ. (1998). Uric acid as an independent risk factor in the treatment of hypertension. Lancet, 352, 670–1
   PubMed Web of Science ®Google Scholar